<DOC>
	<DOC>NCT02413567</DOC>
	<brief_summary>The purpose of this study is to evaluate the Fractyl Duodenal Mucosal Resurfacing (DMR) Procedure for the treatment of Type 2 Diabetes.</brief_summary>
	<brief_title>Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>28 75 years of age Diagnosed with Type 2 Diabetes for less than 10 years HbA1c of 7.5 10.0% (5986 mmol/mol) BMI ≥ 24 and ≤ 40 kg/m2 Diagnosed with Type 1 Diabetes or with a history of ketoacidosis Probable insulin production failure, defined as fasting C Peptide serum &lt;1 ng/mL (333pmol/l) Current use of Insulin Use of GLP1 analogues Active and uncontrolled GERD defined as grade III esophagitis or greater Upper gastrointestinal conditions such as ulcers, gastric varices, strictures, congenital or acquired intestinal telangiectasia</criteria>
	<gender>All</gender>
	<minimum_age>28 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>